De novo donor‐specific HLA antibodies after combined intestinal and vascularized composite allotransplantation — a retrospective study

De novo donor‐specific HLA antibodies after combined intestinal and vascularized composite allotransplantation — a retrospective study

Combining vascularized composite allotransplantation (VCA) with intestinal transplantation to achieve primary abdominal closure has become a feasible procedure. Besides facilitating closure, the abdominal wall can be used to monitor intestinal rejection. As the inclusion of a VCA raises the possibil...

Detaylı Bibliyografya
Asıl Yazarlar:	Weissenbacher, A, Vrakas, G, Chen, M, Reddy, S, Allan, P, Giele, H, Barnardo, M, Vaidya, A, Friend, P, Fuggle, S
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Wiley 2017

Benzer Materyaller

Meeting report of the 13th Congress of the International Society of Vascularized Composite Allotransplantation
Yazar:: Weissenbacher, A, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

The deceased donor score system as tool to guide preservation strategies before organ recovery and HLA-match
Yazar:: Plata-Munoz, J, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Effect of alemtuzumab or basiliximab induction therapy on graft function and survival of kidneys from donors after cardiac death.
Yazar:: Plata-Munoz, J, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

The impact of intestinal transplantation on quality of life
Yazar:: Ambrose, T, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Preclinical Studies in Vascularized Composite Allotransplantation
Yazar:: Andreea Grosu-Bularda, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Perfusion decellularization for vascularized composite allotransplantation
Yazar:: Danielle L Nicholls, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

Cell therapy in vascularized composite allotransplantation
Yazar:: Madonna Rica Anggelia, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

Patient Advocacy in Vascularized Composite Allotransplantation
Yazar:: James Benedict
Baskı/Yayın Bilgisi: (2022-07-01)

Sensitization and Desensitization in Vascularized Composite Allotransplantation
Yazar:: Dimitrios Moris, ve diğerleri
Baskı/Yayın Bilgisi: (2021-08-01)

Costimulation Blockade in Vascularized Composite Allotransplantation
Yazar:: Dimitrios Giannis, ve diğerleri
Baskı/Yayın Bilgisi: (2020-09-01)

Defining chronic rejection in vascularized composite allotransplantation—The American Society of Reconstructive Transplantation and International Society of Vascularized Composite Allotransplantation chronic rejection working group: 2018 American Society of Reconstructive Transplantation meeting report and white paper Research goals in defining chronic rejection in vascularized composite allotransplantation
Yazar:: Christina L Kaufman, ve diğerleri
Baskı/Yayın Bilgisi: (2020-07-01)

The natural history of de novo donor-specific HLA antibodies after kidney transplantation
Yazar:: Covadonga López del Moral, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

Impact of monoclonal antibody based-induction therapy on postoperative graft function and survival of kidneys from non-heart-beating donors.
Yazar:: Plata-Munoz, J, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

New insights into maladaptive vascular responses to donor specific HLA antibodies in organ transplantation
Yazar:: Adriana Franco-Acevedo, ve diğerleri
Baskı/Yayın Bilgisi: (2023-04-01)

The Need for Inducing Tolerance in Vascularized Composite Allotransplantation
Yazar:: Kadiyala V. Ravindra, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Immunogenicity and tolerance induction in vascularized composite allotransplantation
Yazar:: Jiahui (Angela) Sun, ve diğerleri
Baskı/Yayın Bilgisi: (2024-02-01)

Current status of vascularized composite tissue allotransplantation
Yazar:: Karoline Edtinger, ve diğerleri
Baskı/Yayın Bilgisi: (2014-04-01)

Recellularization of Bioengineered Scaffolds for Vascular Composite Allotransplantation
Yazar:: Aisha Adil, ve diğerleri
Baskı/Yayın Bilgisi: (2022-05-01)

A Lifesaving View of Vascularized Composite Allotransplantation
Yazar:: Katrina A Bramstedt PhD, MA
Baskı/Yayın Bilgisi: (2018-06-01)

The deceased donor score system in kidney transplants from deceased donors after cardiac death.
Yazar:: Plata-Munoz, J, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Evaluation of the XM-ONE assay and the role of endothelial cell antibodies in recipients of living donor renal transplants
Yazar:: Procter, J, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Need for Kidney Transplantation Following Vascularized Composite Allotransplantation: An International, Multi-Center Experience
Yazar:: J. Reed McGraw, BS, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Review of the Early Diagnoses and Assessment of Rejection in Vascularized Composite Allotransplantation
Yazar:: Ravi Starzl, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Novel Osteomyocutaneous Flap Model for Vascularized Composite Allotransplantation
Yazar:: David L. Tran, ve diğerleri
Baskı/Yayın Bilgisi: (2024-09-01)

Detection of HLA-specific IGG antibodies using single recombinant HLA alleles: the MonoLISA assay.
Yazar:: Barnardo, M, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Evaluation of the XM-ONE (R) assay and the role of endothelial cell antibodies in recipients of living donor renal transplants
Yazar:: Procter, J, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Preemptive Treatment of De Novo Donor Specific Anti-HLA Antibodies With IVIG Monotherapy after Lung Transplantation
Yazar:: Jennifer K. McDermott, ve diğerleri
Baskı/Yayın Bilgisi: (2024-09-01)

Molecular Signature Associated With Acute Rejection in Vascularized Composite Allotransplantation
Yazar:: Michael F. Cassidy, MD, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Quantification of donor microchimerism in sex-mismatched porcine allotransplantation by competitive PCR
Yazar:: Nancy Morin, ve diğerleri
Baskı/Yayın Bilgisi: (2004-07-01)

Successful Single Donor Islet Allotransplantation in the Streptozotocin Diabetes Rat Model
Yazar:: Henning Jahr, ve diğerleri
Baskı/Yayın Bilgisi: (2002-09-01)

The association between HLA-DR, DQ antigens and vulvar lichen sclerosus in UK
Yazar:: Gao, X, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Allogeneic HLA Humoral Immunogenicity and the Prediction of Donor-Specific HLA Antibody Development
Yazar:: Vadim Jucaud
Baskı/Yayın Bilgisi: (2024-07-01)

Preservation solutions for attenuation of ischemia–reperfusion injury in vascularized composite allotransplantation
Yazar:: Shaishav Datta, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

Mesenchymal Stem Cells as Immunomodulators in a Vascularized Composite Allotransplantation
Yazar:: Yur-Ren Kuo, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Site-Specific Immunosuppression in Vascularized Composite Allotransplantation: Prospects and Potential
Yazar:: Jonas T. Schnider, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Cell therapies and its derivatives as immunomodulators in vascularized composite allotransplantation
Yazar:: Chao-Hsin Huang, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Incorporating Trauma-informed Approaches to Care in Vascularized Composite Allotransplantation
Yazar:: Erika Thys, BA, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Cellular activation pathways and interaction networks in vascularized composite allotransplantation
Yazar:: Leonard Knoedler, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

Ensuring Racial and Ethnic Inclusivity in Facial Vascularized Composite Allotransplantation
Yazar:: Martin Kauke-Navarro, MD, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01)

Perspectives on the Use of Mesenchymal Stem Cells in Vascularized Composite Allotransplantation
Yazar:: Jan A. Plock, ve diğerleri
Baskı/Yayın Bilgisi: (2013-07-01)